COST-EFFECTIVENESS ANALYSIS (CEA) BETWEEN ERLOTINIB AND GEFITINIB FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN THAILAND

被引：0
作者：
Prasongsook, Naiyarat [1 ]
Jaruhathai, Sureerat [1 ]
Maoleekulpairoj, Savitree [1 ]
Sooksriwong, Chaoncin [1 ]
机构：
[1] Mahidol Univ, Fac Pharm, Bangkok 10700, Thailand
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
TK1; Cost-effectiveness; gefitinib; erlotinib;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1245 / S1246
页数：2
相关论文
共 50 条
[41]   THE ANALYSIS OF INFLUENCE OF CLINICAL PREDICTORS ON THE RESULTS OF TREATMENT WITH ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) [J].
Salajka, Frantisek ;
Pesek, Milos ;
Krejci, Jana ;
Skrickova, Jana ;
Zatloukal, Petr ;
Koubkova, Leona ;
Grygarkova, Ivona ;
Hrnciarik, Michal ;
Sticha, Michal .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1293-S1294
[42]   Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer [J].
Cho, Sun Mi ;
Lee, Hye Sun ;
Jeon, Soyoung ;
Kim, Yoonjung ;
Kong, Sun-Young ;
Lee, Jin Kyung ;
Lee, Kyung-A .
ANNALS OF LABORATORY MEDICINE, 2023, 43 (06) :605-613
[43]   Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non-small cell lung cancer: A network meta-analysis [J].
Liu, Yuanyuan ;
Zhang, Yu ;
Feng, Gangling ;
Niu, Qiang ;
Xu, Shangzhi ;
Yan, Yizhong ;
Li, Shugang ;
Jing, Mingxia .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) :4017-4032
[44]   The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib [J].
Grossi, Francesco ;
Rijavec, Erika ;
Dal Bello, Maria Giovanna ;
Defferrari, Carlotta ;
Brianti, Annalisa ;
Barletta, Giulia ;
Genova, Carlo ;
Murolo, Carmelina ;
Cosso, Maurizio ;
Fontanini, Gabriella ;
Boldrini, Laura ;
Truini, Mauro ;
Pronzato, Paolo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) :1407-1412
[45]   Gefitinib and Afatinib Treatment in an Advanced Non-small Cell Lung Cancer (NSCLC) Patient Undergoing Hemodialysis [J].
Bersanelli, Melissa ;
Tiseo, Marcello ;
Artioli, Fabrizio ;
Lucchi, Leonardo ;
Ardizzoni, Andrea .
ANTICANCER RESEARCH, 2014, 34 (06) :3185-3188
[46]   Erlotinib in advanced non-small-cell lung cancer after gefitinib failure [J].
Zheng-Tao Zhou ;
Xin-Hua Xu ;
Qing Wei ;
Ming-qian Lu ;
Jie Wang ;
Cai-Hong Wen .
Cancer Chemotherapy and Pharmacology, 2009, 64 :1123-1127
[47]   The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib [J].
Francesco Grossi ;
Erika Rijavec ;
Maria Giovanna Dal Bello ;
Carlotta Defferrari ;
Annalisa Brianti ;
Giulia Barletta ;
Carlo Genova ;
Carmelina Murolo ;
Maurizio Cosso ;
Gabriella Fontanini ;
Laura Boldrini ;
Mauro Truini ;
Paolo Pronzato .
Cancer Chemotherapy and Pharmacology, 2012, 69 :1407-1412
[48]   Successful treatment with erlotinib of severe neutropenia induced by gefitinib in a patient with advanced non-small cell lung cancer [J].
Araya, Tomoyuki ;
Kasahara, Kazuo ;
Demura, Yoshiki ;
Matsuoka, Hiroki ;
Nishitsuji, Masaru ;
Nishi, Koichi .
LUNG CANCER, 2013, 80 (03) :344-346
[49]   Erlotinib Vs. Gefitinib in advanced or metastatic non-small cell lung cancer: An indirect comparison of efficacy [J].
Carlos-Rivera, F. ;
Araceli, Aguirre-Granados ;
Jocelyn, Ramirez-Gamez .
GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (05) :222-230
[50]   Erlotinib in advanced non-small-cell lung cancer after gefitinib failure [J].
Zhou, Zheng-Tao ;
Xu, Xin-Hua ;
Wei, Qing ;
Lu, Ming-qian ;
Wang, Jie ;
Wen, Cai-Hong .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) :1123-1127
12345